Cargando…
Combating COVID-19 with mesenchymal stem cell therapy
The COVID-19 disease is caused by a positive stranded RNA virus called SARS-CoV-2. The virus mainly targets the pulmonary epithelial cells as it’s initial site of infection by letting its surface spike protein interact and bind to the host ACE2 receptor. The internalization and gradual replication o...
Autores principales: | Rajarshi, Keshav, Chatterjee, Aroni, Ray, Shashikant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224671/ https://www.ncbi.nlm.nih.gov/pubmed/32420049 http://dx.doi.org/10.1016/j.btre.2020.e00467 |
Ejemplares similares
-
BCG vaccination strategy implemented to reduce the impact of COVID-19: Hype or Hope?
por: Rajarshi, Keshav, et al.
Publicado: (2020) -
Nucleic acid-based therapy for coronavirus disease 2019
por: Piyush, Ravikant, et al.
Publicado: (2020) -
Convalescent plasma therapy: a promising coronavirus disease 2019 treatment strategy
por: Piyush, Ravikant, et al.
Publicado: (2020) -
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19
por: Rajarshi, Keshav, et al.
Publicado: (2021)